Abstract:
A simple, accurate and precise UV spectrophotometric methods and RP-HPLC method was
developed and validated for simultaneous estimation of acetaminophen and pamabrom in
bulk and tablet dosage form. In simultaneous equation method determination was carried out
at 242.8 nm λmax of Acetaminophen and 279 nm λmax of pamabrom. The linearity range lies
between 3.25-19.5 μg/ml for acetaminophen and 0.25-1.75 μg/ml for pamabrom at their
respective wavelengths. Both the drugs were found in good agreement with the label claimed
in the marketed formulation. In the tablets both the drugs were estimated as 97.24% and
102.11% Acetaminophen and Pamabrom respectively. Calibration curves were linear with
correlation coefficient 0.999 and 0.998 over the concentration range of 3.75-19.5 μg/ml and
0.25-1.75 μg/ml for Acetaminophen and Pamabrom respectively. The RP-HPLC method for
simultaneous estimation of Acetaminophen and Pamabrom was developed. The separation
was achieved on a Phenomenex luna ODS C18 (250mm X 4.6 mm i.d., 5 μm particle size)
with an isocratic mixture of Methanol:Water (50:50) pH-3.0. The mobile phase at a flow rate
of 1.0 ml/min, Injection volume 20μl and wavelength of detection was kept at 265 nm. The
retention time of Acetaminophen and Pamabrom was 2.9±0.2min and 4.8±0.2min
respectively. The linearity of a simple, accurate, precise RP-HPLC method was developed and validated for simultaneous estimation of Acetaminophen and Pamabrom in bulk and
tablet dosage form. The proposed method was investigated in the range of 3.25-19.5μg/ml
and 0.25-1.5μg/ml for Acetaminophen and Pamabrom, respectively. Correlation coefficient was 0.998 and 0.998 for Acetaminophen and Pamabrom, respectively. The limit of detection was 0.222μg/ml and 0.055μg/ml for Acetaminophen and Pamabrom respectively and the limit of quantification was 0.673μg/ml and 0.169μg/ml for Acetaminophen and Pamabrom, respectively.
